Definitive Healthcare (NASDAQ:DH) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Definitive Healthcare (NASDAQ:DH) announced its earnings results on Monday. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01, FiscalAI reports. Definitive Healthcare had a positive return on equity of 4.04% and a negative net margin of 76.04%.

Definitive Healthcare Trading Down 2.1%

NASDAQ:DH traded down $0.01 during mid-day trading on Monday, reaching $0.70. 172,013 shares of the company’s stock traded hands, compared to its average volume of 358,310. The company has a 50 day moving average price of $0.78 and a 200-day moving average price of $1.12. The firm has a market capitalization of $73.71 million, a price-to-earnings ratio of -0.43, a PEG ratio of 11.51 and a beta of 1.35. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.75 and a quick ratio of 1.75. Definitive Healthcare has a 12-month low of $0.62 and a 12-month high of $4.35.

Wall Street Analyst Weigh In

Several research analysts have commented on DH shares. Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a research note on Sunday, July 26th. Robert W. Baird set a $1.10 target price on shares of Definitive Healthcare in a research report on Friday, May 8th. Zacks Research raised shares of Definitive Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Definitive Healthcare in a research note on Wednesday, June 3rd. Finally, Bank of America reiterated an “underperform” rating and issued a $0.70 price objective on shares of Definitive Healthcare in a report on Monday, June 29th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $1.88.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. lifted its position in shares of Definitive Healthcare by 5.8% in the 4th quarter. Invesco Ltd. now owns 117,427 shares of the company’s stock worth $337,000 after purchasing an additional 6,400 shares during the period. XTX Topco Ltd raised its stake in Definitive Healthcare by 57.5% in the fourth quarter. XTX Topco Ltd now owns 75,306 shares of the company’s stock worth $216,000 after buying an additional 27,495 shares in the last quarter. Occudo Quantitative Strategies LP purchased a new stake in Definitive Healthcare in the fourth quarter worth about $95,000. Millennium Management LLC boosted its position in Definitive Healthcare by 230.9% during the 4th quarter. Millennium Management LLC now owns 332,087 shares of the company’s stock valued at $953,000 after acquiring an additional 231,743 shares in the last quarter. Finally, Inspire Investing LLC boosted its position in Definitive Healthcare by 505.7% during the 4th quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock valued at $2,006,000 after acquiring an additional 583,562 shares in the last quarter. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.